2022
DOI: 10.4103/aip.aip_131_21
|View full text |Cite
|
Sign up to set email alerts
|

Use of Bupropion and Topiramate in Management of Tianeptine Abuse in a Young Male with Dysthymia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…Fortunately, there is preliminary evidence through case reports to support off-label use of buprenorphine in the treatment of tianeptine withdrawal when used as a taper (Nabil et al, 2018). Other case reports suggest that buprenorphine can be used for maintenance to mitigate risk of tianeptine use recurrence (Trowbridge & Walley, 2019), and another case report has suggested bupropion and topiramate to mitigate tianeptine misuse (Chawla & Kar, 2022).…”
mentioning
confidence: 99%
“…Fortunately, there is preliminary evidence through case reports to support off-label use of buprenorphine in the treatment of tianeptine withdrawal when used as a taper (Nabil et al, 2018). Other case reports suggest that buprenorphine can be used for maintenance to mitigate risk of tianeptine use recurrence (Trowbridge & Walley, 2019), and another case report has suggested bupropion and topiramate to mitigate tianeptine misuse (Chawla & Kar, 2022).…”
mentioning
confidence: 99%